 Connection
David Simpson to Tumor Necrosis Factor-alpha
This is a "connection" page, showing publications David Simpson has written about Tumor Necrosis Factor-alpha.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.037 |
|
|
|
-
Sharma S, Mishra R, Walker BL, Deshmukh S, Zampino M, Patel J, Anamalai M, Simpson D, Singh IS, Kaushal S, Kaushal S. Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death. Cell Stress Chaperones. 2015 Jan; 20(1):185-201.
Score: 0.022
-
Geraci A, Di Rocco A, Liu M, Werner P, Tagliati M, Godbold J, Simpson D, Morgello S. AIDS myelopathy is not associated with elevated HIV viral load in cerebrospinal fluid. Neurology. 2000 Aug 08; 55(3):440-2.
Score: 0.008
-
Jacobson JM, Spritzler J, Fox L, Fahey JL, Jackson JB, Chernoff M, Wohl DA, Wu AW, Hooton TM, Sha BE, Shikuma CM, MacPhail LA, Simpson DM, Trapnell CB, Basgoz N. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. J Infect Dis. 1999 Jul; 180(1):61-7.
Score: 0.008
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|